Stanford Center for Clinical & Translational Education and Research (Spectrum)

斯坦福临床中心

• 批准号: 10664842
• 负责人: Ruth M O'Hara
• 金额: $ 874.47万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-15 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10664842
• 关键词: Acceleration; Achievement; Area; Assessment tool; Biometry; Biotechnology; Caregivers; Child; Clinical Research; Collaborations; Communities; Data; Data Analytics; Development; Discipline; Education; Effectiveness; Elderly; Ensure; Environment; Ethics; Evaluation; Federal Government; Feedback; Foundations; Future; Goals; Health; Healthcare Systems; Home; Human; Human Subject Research; Individual; Industry; Informatics; Information Systems; Infrastructure; Institution; Knowledge; Leadership; Life Cycle Stages; Local Government; Longevity; Maintenance; Methodology; Methods; Minority; Mission; Names; Outcome; Patient Representative; Patients; Performance; Personal Satisfaction; Persons; Population; Population Heterogeneity; Population Sciences; Positioning Attribute; Process; Productivity; Rare Diseases; Research; Research Methodology; Research Personnel; Research Support; Resources; Science; Series; Services; Special Population; State Government; Testing; Training; Translating; Translational Research; Underrepresented Minority; Universities; Vision; Vulnerable Populations; Woman; Work; Workforce Development; career development; clinical center; clinical implementation; community engagement; cost; design; education resources; health care delivery; human subject protection; implementation research; implementation science; improved; informatics tool; innovation; medically underserved; member; multidisciplinary; next generation; programs; research study; skills; success; tool; translational pipeline

Contact PD/PI: Cullen, Mark R. 0. Overall: Abstract The mission of Spectrum, Stanford's CTSA-supported research Hub, is to transform clinical and translational research and education at Stanford and across the Hub network to make it more effective at discovering and implementing data-driven strategies to serve the health needs of individuals and the population and to disseminate that knowledge to trainees and the public. Spectrum's programs are designed to extend from the earliest stages of the translational pipeline to the “final mile” of implementation science at the patient and population levels. During the next five years, Spectrum will leverage the gains and achievements made over the past decade, our institutional strengths and resources, and advancements in the focus of the national network of CTSA Hubs to nurture an innovative and collaborative workforce that can transfer health discoveries from the University to patients and the community. Spectrum's purpose is to support essential resources and educational opportunities to ensure the current and ongoing success of this mission. To that end, our first overarching aim is to educate the next generation of investigators who make up the clinical and translational research (CTR) “workforce” with the skills to carry out innovative clinical, translational, and implementation research to meet the opportunities and challenges of health- care delivery and wellness maintenance in the 21st Century. Our second overarching aim is to maximize community engagement and team science to ensure that the products of our research benefit all segments of the population including special populations, people with rare diseases, minorities and women, vulnerable populations such as children and the elderly, and the medically underserved. Our third overarching aim is to create an institutional home that provides investigative teams with ready access to the methods, processes, services, and assessment tools necessary to efficiently translate those discoveries that will substantially alter health outcomes in order to directly improve the health and well-being of individuals and the population. Finally, our fourth overarching aim is to develop informatics-based CTR methods, processes, services, and assessment tools necessary to efficiently translate discoveries into improved health outcomes while reducing costs, promoting compliance, and ensuring data availability. Such enhancements will broadly facilitate our CTR mission. With Spectrum's strong track record of accomplishments, supportive institutional environment, well- developed infrastructure and leadership, and our ever-expanding network of collaborators, including health-care systems, other Hubs, and community partners, we are well-positioned to execute on our vision for the next five years. Page 173 Project Summary/Abstract Contact PD/PI: Cullen, Mark R. 0. Overall: Narrative The mission of Spectrum, Stanford University's CTSA-supported Hub, is to transform clinical and translational research and education (CTRE) to ultimately serve the present and future health needs of individuals and the population. Spectrum will support essential resources and educational opportunities in four broad areas, i.e., innovative translational discoveries, team science approaches, innovative training methods for the CTR workforce, and good stewardship of all resources, to ensure the current and ongoing success of this mission. To achieve its mission, Spectrum will work closely with its local, regional, and national partners, including and especially with the other Hubs in the CTSA Consortium, while using a series of well validated metrics to continuously assess and improve performance. Page 174

联络PD/PI: Cullen， Mark R。

项目成果

Evaluating the Effectiveness of Septoplasty for Nasal Valve Collapse: A Retrospective Study.

评估鼻中隔成形术治疗鼻瓣塌陷的有效性：一项回顾性研究。

• DOI: 10.1089/fpsam.2023.0218
• 发表时间: 2023
• 期刊: Facial plastic surgery & aesthetic medicine
• 影响因子: 2
• 作者: Green,Allen;Wei,EricX;Kandathil,CherianK;Youn,GunMin;Shah,JayP;Most,SamP
• 通讯作者: Most,SamP

Training Staff Across the Veterans Affairs Health Care System to Use Mobile Mental Health Apps: A National Quality Improvement Project.

• DOI: 10.2196/41773
• 发表时间: 2023-01-12
• 期刊: JMIR MENTAL HEALTH
• 影响因子: 5.2
• 作者: McGee-Vincent, Pearl;Mackintosh, Margaret -Anne;Jamison, Andrea L.;Juhasz, Katherine;Becket-Davenport, Colleen;Bosch, Jeane;Avery, Timothy J.;Glamb, Lauren;Hampole, Shilpa
• 通讯作者: Hampole, Shilpa

Neurofibromatosis Type 1 and Risk of Skin Cancer.

1 型神经纤维瘤病和皮肤癌的风险。

• DOI: 10.1001/jamadermatol.2022.3083
• 发表时间: 2022
• 期刊: JAMA dermatology
• 影响因子: 10.9
• 作者: Trinh,Pavin;Li,Shufeng;Sarin,KavitaYang
• 通讯作者: Sarin,KavitaYang

Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited.

与一般人群相比，遗传性出血性毛细血管扩张症 (HHT) 患者的鼻出血和毛细血管扩张频率：库拉索诊断标准重新审视。

• DOI: 10.1016/j.gim.2023.100865
• 发表时间: 2023
• 期刊: Genetics in medicine : official journal of the American College of Medical Genetics
• 作者: McDonald,Jamie;Kornish,Jenna;Stevenson,DavidA;Hanson-Kahn,Andrea;Balch,Heather;James,John;Naik,Hetanshi;Whitehead,KevinJ
• 通讯作者: Whitehead,KevinJ

Is Public Interest Associated with Real-World Management of Ankyloglossia?

公共利益与现实世界的强舌症管理有关吗？

• DOI: 10.1002/ohn.643
• 发表时间: 2024
• 期刊: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
• 作者: Naseem,DanialF;Sheth,AmarH;Cheng,AlanG;Qian,ZJason
• 通讯作者: Qian,ZJason